Skip to main content
gene_symbol
ERBB2
hgnc_id
HGNC:3430
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
The ADC binds HER2, is internalized, and releases the topoisomerase I inhibitor deruxtecan inside the cell, causing DNA damage and apoptosis; Fc-mediated ADCC also contributes, with a membrane-permeable payload enabling bystander killing.
enzyme_product
On
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Trastuzumab binds the extracellular domain of the HER2 receptor tyrosine kinase
trial_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06548178
disease_id_num_tar_ref
2120
drug_id_num_tar_ref
5671